RPAF-AH
RPAF-AH Uses, Dosage, Side Effects, Food Interaction and all others data.
RPAF-AH is under investigation in clinical trial NCT00037687 (Safety and Efficacy of Recombinant Human Platelet-activating Factor Acetylhydrolase for the Treatment of Severe Sepsis).
| Trade Name | RPAF-AH |
| Generic | Epafipase |
| Epafipase Other Names | Epafipase, RPAF-AH |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here RPAF-AH
